Cart (0)
  • No items in cart.
Total
$0
There is a technical issue about last added item. You can click "Report to us" button to let us know and we resolve the issue and return back to you or you can continue without last item via click to continue button.
Home
Content
Tour
eLibrary
Store
Search book title
Enter keywords for book title search
Search book content
Enter keywords for book content search
Filters:
FORMAT
BOOKS
All Books
PACKAGES
All Packages
EDITION
to
PUBLISHER
AABC
(1)
AAMI
(326)
ACI
(573)
AISC
(44)
ASA
(234)
ASCE
(969)
ASHRAE
(652)
ASME
(2114)
ASSE
(64)
ASTM
(92448)
AWC
(54)
AWWA
(541)
BHMA
(117)
BICSI
(33)
BIFMA
(21)
BOMA
(20)
BSI
(93277)
CHD
(3)
CRSI
(17)
IAHSS
(1)
IAPMO
(351)
ICC
(300)
IEEE
(6217)
IES
(240)
ISEA
(16)
Joint Commission
(177)
Joint Commission Int.
(1)
NETA
(5)
NFPA
(1635)
TCNA
(16)
TMS
(19)
USGBC
(28)
WILEY
(4)
 
AR
(6)
AZ
(7)
CA
(115)
CT
(3)
FL
(57)
ID
(5)
IL
(5)
IN
(1)
KY
(1)
LA
(2)
MI
(25)
MN
(26)
NC
(27)
NJ
(13)
NY
(61)
OH
(24)
OR
(22)
PA
(7)
RI
(8)
SC
(20)
SD
(1)
TX
(3)
VA
(50)
VT
(6)
WA
(31)
CONTENT TYPE
 Act
 Admin Code
 Announcements
 Bill
 Book
 CADD File
 CAN
 CEU
 Charter
 Checklist
 City Code
 Code
 Commentary
 Comprehensive Plan
 Conference Paper
 County Code
 Course
 DHS Documents
 Document
 Errata
 Executive Regulation
 Federal Guideline
 Firm Content
 Guideline
 Handbook
 Interpretation
 Journal
 Land Use and Development
 Law
 Legislative Rule
 Local Amendment
 Local Code
 Local Document
 Local Regulation
 Local Standards
 Manual
 Model Code
 Model Standard
 Notice
 Ordinance
 Other
 Paperback
 PASS
 Periodicals
 PIN
 Plan
 Policy
 Product
 Product - Data Sheet
 Program
 Provisions
 Requirements
 Revisions
 Rules & Regulations
 Standards
 State Amendment
 State Code
 State Manual
 State Plan
 State Standards
 Statute
 Study Guide
 Supplement
 Sustainability
 Technical Bulletin
 All
  • BSI
    BS ISO 20069:2019 Guidance for assessment and evaluation of changes to drug delivery systems
    Edition: 2019
    $473.45
    / user per year

Description of BS ISO 20069:2019 2019

This document provides guidance for assessment and evaluation of planned changes to drug delivery systems that are integral with, packaged with, or cross-labelled for use with a specified medicinal product. This document is applicable to the drug delivery system’s lifecycle from registration clinical studies to end-of-life. This document is applicable to the assessment of changes within the following drug delivery systems:

— needle-based injection systems for medical use;

— aerosol drug delivery devices;

— needle-free injectors for medical use.

NOTE

These are covered by the ISO 11608 series, ISO 20072 and ISO 21649, respectively.

This document might also be useful for assessing and evaluate changes to other drug delivery devices or systems.

Examples of changes that are within the scope of this document include but are not limited to the following:

  1. the same route of administration (e.g. change resulting in including a marketed prefilled syringe to an autoinjector);

  2. changes to the drug delivery system design (e.g. change in configuration or layout of electrical and mechanical components);

  3. changes to the medicinal product that affect the drug delivery system; including the primary container closure (e.g. viscosity, particle size);

  4. changes in production or handling of the drug delivery system (e.g. process scale, manual to automated assembly, glue bond to sonic weld, mould cavitation, sterilization, storage, transportation, work instructions or methods);

  5. changes in component materials or source of supply;

  6. changes in software, including changes related to cybersecurity, encryption and connectivity;

  7. changes in the user interface, including packaging;

  8. changes to labelling and/or instructions for use.

Revisions or additions of software are within the scope of this document. The software can either be integrated into the physical drug delivery system, separate, or both.

The applicability of this document to non-integrated software is relevant to the extent that those software changes can impact the drug delivery system and/or impact how users interact with it.

Depending on the nature of the change, there can be additional assessments and resulting activities, which can be outside the scope of this document.

This document does not provide guidance for defining the objective of the change, nor the various potential opportunities/options for fulfilling this objective.



Standard NumberBS ISO 20069:2019
TitleGuidance for assessment and evaluation of changes to drug delivery systems
StatusDefinitive
Publication Date2019-08-07
Identical National Standard OfISO 20069
DescriptorsExternal, Electrical safety, Safety measures, Hazards, Watertightness tests, Artificial organs, Pacemakers, Equipment safety, Environmental testing, Electrical equipment, Electrical insulation, Leakage currents, Cardiology, Electrical medical equipment, Electronic equipment and components, Medical equipment, Marking
ICS11.040.40 Implants for surgery, prosthetics and orthotics, 11.040.01 Medical equipment in general
CommitteeCH/84
ISBN978 0 580 96194 6
PublisherBSI
Pages46

About BSI

BSI Group, also known as the British Standards Institution is the national standards body of the United Kingdom. BSI produces technical standards on a wide range of products and services and also supplies certification and standards-related services to businesses.
GROUPS
X